Aco Radujevic

Dr. Aco Radujevic is a Principal Scientist at GSK, where his work sits at the intersection of synthetic organic chemistry, drug discovery, AI/ML and laboratory automation for early-phase drug discovery programs. He earned his Ph.D. in Chemistry from the Center for Photochemical Sciences at Bowling Green State University, followed by two years as a scientist at NIH/NCATS before joining GSK. He has developed chemistry synthesis and automation platforms that integrate AI/ML with hardware and software systems to accelerate small-molecule drug discovery. His research bridges medicinal chemistry with nano- and milliscale high-throughput automated synthesis and screening, bringing novel therapeutic modalities from bench-scale concept to scalable, automated pipelines. He is based in the greater Philadelphia area.